Controlled clinical trial of pentoxifylline versus cinnarizine in the treatment of labyrinthine disorders.
Ganança M M, Mangabeira Albernaz P L, Caovilla H H, +1 more·Pharmatherapeutica
Seventy-six patients with labyrinthine diseases of vascular origin were treated in a 6-week double-blind comparative study with either 400 mg pentoxifylline ('Trental') or 75 mg cinnarizine 3-times daily. Clinical evaluations, supported by audiological tests and vectornystagmography, were carried out before and after t…